Erratum to Giangrande et al. “Clinical evaluation of glycoPEGylated recombinant FVIII: Efficacy and safety in severe haemophilia A” (Thromb Haemost 2017; 117: 252-261)

In the original article by Giangrande et al. “Clinical evaluation of glycoPEGylated recombinant FVIII: Efficacy and safety in severe haemophilia A” (Thromb Haemost 2017; 117: 252-261), there is a reference on page 257 to Figure 4 which does not exist. We appologize for this oversight. https://doi.org/10.1160/TH17060001 Thromb Haemost 2017; 117: 1163